ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,527 | +10.3% | 429 | +46.4% | 0.00% | 0.0% |
| Q2 2023 | $10,448 | +112.0% | 293 | +51.0% | 0.00% | 0.0% |
| Q1 2023 | $4,928 | -81.8% | 194 | -71.0% | 0.00% | -66.7% |
| Q4 2022 | $27,094 | +12.9% | 668 | -8.0% | 0.00% | -25.0% |
| Q3 2022 | $24,000 | -4.0% | 726 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $25,000 | -24.2% | 719 | +0.1% | 0.00% | -20.0% |
| Q1 2022 | $33,000 | -56.6% | 718 | -37.2% | 0.01% | -58.3% |
| Q4 2021 | $76,000 | +7500.0% | 1,144 | +10300.0% | 0.01% | – |
| Q3 2021 | $1,000 | -92.9% | 11 | -94.8% | 0.00% | -100.0% |
| Q1 2021 | $14,000 | -67.4% | 213 | -78.7% | 0.00% | -75.0% |
| Q3 2020 | $43,000 | – | 1,000 | – | 0.01% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2019 | $33,000 | -21.4% | 515 | -65.7% | 0.01% | -31.2% |
| Q3 2019 | $42,000 | +7.7% | 1,500 | 0.0% | 0.02% | +6.7% |
| Q2 2019 | $39,000 | -46.6% | 1,500 | -62.5% | 0.02% | -48.3% |
| Q1 2019 | $73,000 | +40.4% | 4,000 | -4.8% | 0.03% | +11.5% |
| Q4 2018 | $52,000 | – | 4,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |